Placebo Effect of Sham Acupuncture for Primary Insomnia: A Meta-Analysis of Randomised Controlled Trials
Abstract
To provide updated evidence from randomised controlled trials (RCTs) on the placebo effect size and influencing factors of sham acupuncture for primary insomnia. A systematic literature review and meta-analysis were conducted in accordance with the PRISMA guidelines. Databases such as PubMed, Cochrane, Embase, Web of Science, China National Knowledge Infrastructure, Wanfang, China Science and Technology Journal Database and Chinese Biological Medicine Database were searched, focusing on sham acupuncture and primary insomnia. RCTs would be included if they compared the clinical efficacy of sham acupuncture before and after the intervention in patients with primary insomnia. The risk of bias of the included studies was evaluated using the Cochrane risk-of-bias tool (version 2.0). A total of 4348 studies were retrieved, and 36 eligible randomised controlled trials were included. The overall risk of bias in 13 studies were considered as high risk, 7 studies were categorised as some concerns and 16 studies were considered as low risk. The results of the meta-analysis showed that sham acupuncture significantly reduced Pittsburgh Sleep Quality Index (PSQI) [weighted mean difference (WMD) = 1.38, (95% confidence interval (CI) = 0.90, 1.86), p < 0.05] and Insomnia Severity Index (ISI) [WMD = 2.58, (95% CI = 1.46-3.69), p < 0.05]. There was no significant change in polysomnography and actigraphy. Sham acupuncture had a certain placebo effect in clinical trials of primary insomnia. The…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.